{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:16:26Z","timestamp":1791918986154,"version":"4.3.4"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":57,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","award":["NSFC 31640027"],"award-info":[{"award-number":["NSFC 31640027"]}],"id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ARC dementia Career Development Research Fellowship","award":["APP 1111611"],"award-info":[{"award-number":["APP 1111611"]}]},{"name":"ARC dementia Career Development Research Fellowship","award":["U1604177"],"award-info":[{"award-number":["U1604177"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1166024"],"award-info":[{"award-number":["GNT1166024"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"National Key Technologies R&D program","doi-asserted-by":"publisher","award":["2018YFA0209800"],"award-info":[{"award-number":["2018YFA0209800"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.mtbio.2020.100055","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:34:46Z","timestamp":1588541686000},"page":"100055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"6","author":[{"given":"G.Y.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9286-947X","authenticated-orcid":false,"given":"R.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.Y.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7997-1026","authenticated-orcid":false,"given":"X.J.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib1","doi-asserted-by":"crossref","DOI":"10.4081\/ni.2015.5885","article-title":"Amyotrophic lateral sclerosis: new perpectives and update","volume":"7","author":"Orsini","year":"2015","journal-title":"Neurol. Int."},{"key":"10.1016\/j.mtbio.2020.100055_bib2","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nature Rev. Disease Prim."},{"key":"10.1016\/j.mtbio.2020.100055_bib3","series-title":"Mayo Clinic Proceedings","first-page":"1617","article-title":"Amyotrophic lateral sclerosis: an update for 2018","author":"Oskarsson","year":"2018"},{"key":"10.1016\/j.mtbio.2020.100055_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fnins.2019.00532","article-title":"Motor neuron susceptibility in ALS\/FTD","volume":"13","author":"Ragagnin","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","article-title":"Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications","volume":"17","author":"Chia","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mtbio.2020.100055_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fncel.2017.00080","article-title":"ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles","volume":"11","author":"Bonafede","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13311-014-0332-8","article-title":"Challenges in the understanding and treatment of amyotrophic lateral sclerosis\/motor neuron disease","volume":"12","author":"Rosenfeld","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mtbio.2020.100055_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","article-title":"ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?","volume":"9","author":"Petrov","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/jps.24322","article-title":"A\u00a0review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders","volume":"104","author":"Mazibuko","year":"2015","journal-title":"J.\u00a0Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.mtbio.2020.100055_bib10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.tibtech.2017.06.002","article-title":"Advances in alzheimer's diagnosis and therapy: the implications of nanotechnology","volume":"35","author":"Hajipour","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib11","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1080\/10717544.2017.1359862","article-title":"Nanotechnology-based drug delivery of ropinirole for Parkinson's disease","volume":"24","author":"Barcia","year":"2017","journal-title":"Drug Deliv."},{"issue":"43","key":"10.1016\/j.mtbio.2020.100055_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201701921","article-title":"Drug delivery to the brain across the blood\u2013brain barrier using nanomaterials","volume":"13","author":"Tsou","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2020.100055_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2016.06.018","article-title":"Targeting the blood-spinal cord barrier: a therapeutic approach to spinal cord protection against ischemia-reperfusion injury","volume":"158","author":"Hu","year":"2016","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood\u2013brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.mtbio.2020.100055_bib15","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1038\/ncomms10465","article-title":"ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function","volume":"7","author":"Sharma","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2020.100055_bib16","first-page":"1","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41593-017-0047-3","article-title":"TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS\/FTD","volume":"21","author":"Chou","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib18","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2020.100055_bib19","first-page":"41","article-title":"Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS","volume":"9","author":"Carr\u00ec","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.mtbio.2020.100055_bib20","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1172\/JCI90607","article-title":"Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia","volume":"127","author":"Lall","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mtbio.2020.100055_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7070469","article-title":"Neuroinflammation and ALS: transcriptomic insights into molecular disease mechanisms and therapeutic targets","volume":"2017","author":"Morello","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.mtbio.2020.100055_bib22","first-page":"1","article-title":"Disrupted neuronal trafficking in amyotrophic lateral sclerosis","author":"Burk","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrneurol.2016.190","article-title":"Gene therapy: gene-editing therapy for neurological disease","volume":"13","author":"McMahon","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.mtbio.2020.100055_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(18)30091-7","article-title":"Riluzole, disease stage and survival in ALS","volume":"17","author":"Dharmadasa","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cell.2017.10.011","article-title":"Edaravone: a new drug approved for ALS","volume":"171","author":"Rothstein","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2174\/1570159X14666160120152423","article-title":"Current therapy of drugs in amyotrophic lateral sclerosis","volume":"14","author":"Lu","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.mtbio.2020.100055_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2019.06.006","article-title":"Histamine beyond its effects on allergy: potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS)","volume":"202","author":"Cinzia","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"46","key":"10.1016\/j.mtbio.2020.100055_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood\u2013brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2020.100055_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fnagi.2014.00173","article-title":"The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosis","volume":"6","author":"Lovejoy","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.mtbio.2020.100055_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029449","article-title":"Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial","volume":"9","author":"Urbi","year":"2019","journal-title":"BMJ open"},{"issue":"5\u20136","key":"10.1016\/j.mtbio.2020.100055_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/21678421.2018.1431786","article-title":"Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach","volume":"19","author":"Funke","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"10.1016\/j.mtbio.2020.100055_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/FJC.0000000000000728","article-title":"Potential of the cardiovascular drug levosimendan in the management of amyotrophic lateral sclerosis: an overview of a working hypothesis","volume":"74","author":"Al-Chalabi","year":"2019","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"issue":"7\u20138","key":"10.1016\/j.mtbio.2020.100055_bib33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/21678421.2019.1632899","article-title":"Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial","volume":"20","author":"Gold","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"6","key":"10.1016\/j.mtbio.2020.100055_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018904","article-title":"Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): study protocol clinical trial (SPIRIT Compliant)","volume":"99","author":"Vucic","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mtbio.2020.100055_bib35","doi-asserted-by":"crossref","first-page":"107986","DOI":"10.1016\/j.neuropharm.2020.107986","article-title":"Disease-Modifying therapies in amyotrophic lateral sclerosis","author":"Chi\u00f2","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mtbio.2020.100055_bib36","series-title":"Delivery of Drugs","first-page":"97","article-title":"Mitochondria-targeted drug delivery in neurodegenerative diseases","author":"Chidambaram","year":"2020"},{"issue":"5","key":"10.1016\/j.mtbio.2020.100055_bib37","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acsomega.9b03735","article-title":"Preclinical pharmacokinetics of complement C5a receptor antagonists PMX53 and PMX205 in mice","volume":"5","author":"Kumar","year":"2020","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.mtbio.2020.100055_bib38","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.mtbio.2020.100055_bib39","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tibtech.2018.01.006","article-title":"Nanotechnology-based strategies for siRNA brain delivery for disease therapy","volume":"36","author":"Zheng","year":"2018","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.mtbio.2020.100055_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fncel.2014.00021","article-title":"Blood-CNS barrier impairment in ALS patients versus an animal model","volume":"8","author":"Garbuzova-Davis","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.mtbio.2020.100055_bib42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood\u2013brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.mtbio.2020.100055_bib43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib44","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nbd.2012.03.040","article-title":"Selective increase of two ABC drug efflux transporters at the blood\u2013spinal cord barrier suggests induced pharmacoresistance in ALS","volume":"47","author":"Jablonski","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166061","article-title":"Effects on P-glycoprotein expression after blood-brain barrier disruption using focused ultrasound and microbubbles","volume":"12","author":"Aryal","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-12426-9","article-title":"First-in-human trial of blood\u2013brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound","volume":"10","author":"Abrahao","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1153568","article-title":"Nanoparticle transport across the blood brain barrier","volume":"4","author":"Grabrucker","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.mtbio.2020.100055_bib48","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharm."},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/ph3020345","article-title":"Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound","volume":"3","author":"Bordet","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"42","key":"10.1016\/j.mtbio.2020.100055_bib50","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1073\/pnas.1213960109","article-title":"Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis","volume":"109","author":"Tesla","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib51","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3762\/bjoc.9.82","article-title":"Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)","volume":"9","author":"Limpert","year":"2013","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.mtbio.2020.100055_bib52","series-title":"BMC Neurol","first-page":"S3","article-title":"Characteristics of compounds that cross the blood-brain barrier","author":"Banks","year":"2009"},{"issue":"12","key":"10.1016\/j.mtbio.2020.100055_bib53","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS","volume":"21","author":"Foust","year":"2013","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.mtbio.2020.100055_bib54","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1124\/dmd.112.044925","article-title":"Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance","volume":"40","author":"Kadam","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib55","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.mtbio.2020.100055_bib56","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"ud Din","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2020.100055_bib57","article-title":"Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs","volume":"2016","author":"Sharma","year":"2016","journal-title":"Sci. Tech. Rep."},{"issue":"11","key":"10.1016\/j.mtbio.2020.100055_bib58","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s40262-018-0655-4","article-title":"Two decades-long journey from Riluzole to Edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics","volume":"57","author":"Dash","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib59","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3892\/or.2017.5718","article-title":"Cancer drug delivery in the nano era: an overview and perspectives","volume":"38","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mtbio.2020.100055_bib60","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J.\u00a0Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejpb.2014.05.004","article-title":"Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art","volume":"87","author":"Gastaldi","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"17","key":"10.1016\/j.mtbio.2020.100055_bib62","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.2174\/0929867311320170006","article-title":"Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier","volume":"20","author":"Tosi","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12951-015-0075-7","article-title":"The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model","volume":"13","author":"Shilo","year":"2015","journal-title":"J.\u00a0Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.mtbio.2020.100055_bib64","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.drudis.2016.02.006","article-title":"Dendrimer technologies for brain tumor","volume":"21","author":"Mishra","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib65","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3762\/bjnano.5.196","article-title":"Carbon-based smart nanomaterials in biomedicine and neuroengineering","volume":"5","author":"Monaco","year":"2014","journal-title":"Beilstein J. Nanotechnol."},{"issue":"51","key":"10.1016\/j.mtbio.2020.100055_bib66","doi-asserted-by":"crossref","first-page":"1803717","DOI":"10.1002\/adma.201803717","article-title":"Effective and targeted human orthotopic glioblastoma xenograft therapy via a multifunctional biomimetic nanomedicine","volume":"30","author":"Zou","year":"2018","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.mtbio.2020.100055_bib67","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/17425247.2018.1517749","article-title":"Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery","volume":"15","author":"Kou","year":"2018","journal-title":"Expet Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib68","first-page":"201","article-title":"A\u00a0phase I\/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis","volume":"1","author":"Ochs","year":"2000","journal-title":"Amyotroph Lateral Scler."},{"issue":"5","key":"10.1016\/j.mtbio.2020.100055_bib69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"A\u00a0phase I, randomised, first-in-human study of an antisense oligonucleotide directed against SOD1 delivered intrathecally in SOD1-familial ALS patients","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.mtbio.2020.100055_bib70","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.1628","article-title":"Concise review: stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future","volume":"32","author":"Lunn","year":"2014","journal-title":"Stem Cell."},{"key":"10.1016\/j.mtbio.2020.100055_bib71","series-title":"Brain Targeted Drug Delivery System","first-page":"321","article-title":"Nanotherapeutic strategies for the treatment of neurodegenerative diseases","author":"Huang","year":"2019"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49028-w","article-title":"Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice","volume":"9","author":"Householder","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/pharmaceutics12020093","article-title":"Targeting small molecule delivery to the brain and spinal cord via intranasal administration of rabies virus glycoprotein (RVG29)-Modified PLGA nanoparticles","volume":"12","author":"Chung","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12951-019-0481-3","article-title":"Intracisternal delivery of PEG-coated gold nanoparticles results in high brain penetrance and long-lasting stability","volume":"17","author":"Spinelli","year":"2019","journal-title":"J.\u00a0Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib75","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","article-title":"ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair","volume":"22","author":"Klim","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mtbio.2020.100055_bib76","first-page":"73","article-title":"Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging","author":"Sahoo","year":"2017","journal-title":"Nanomed. Cancer, Pan Stanford"},{"issue":"14","key":"10.1016\/j.mtbio.2020.100055_bib77","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/smll.201100442","article-title":"More effective nanomedicines through particle design","volume":"7","author":"Wang","year":"2011","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.mtbio.2020.100055_bib78","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/14656566.2017.1319937","article-title":"Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis","volume":"18","author":"Sawada","year":"2017","journal-title":"Expet Opin. Pharmacother."},{"issue":"10","key":"10.1016\/j.mtbio.2020.100055_bib79","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of nanoparticles","volume":"25","author":"Choi","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.mtbio.2020.100055_bib80","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.drudis.2014.04.011","article-title":"Is nanotechnology a boon for oral drug delivery?","volume":"19","author":"Agrawal","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"19","key":"10.1016\/j.mtbio.2020.100055_bib81","doi-asserted-by":"crossref","first-page":"1704307","DOI":"10.1002\/adma.201704307","article-title":"Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials","volume":"30","author":"Bourquin","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2020.100055_bib82","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J.\u00a0Contr. Release"},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib83","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release","volume":"116","author":"Kamaly","year":"2016","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.mtbio.2020.100055_bib84","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1021\/acsnano.8b01994","article-title":"Simultaneous blood\u2013brain barrier crossing and protection for stroke treatment based on edaravone-loaded ceria nanoparticles","volume":"12","author":"Bao","year":"2018","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib85","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/pr.111.005363","article-title":"Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles","volume":"64","author":"Morachis","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib86","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bmc.2011.07.048","article-title":"Cleavable linkers in chemical biology","volume":"20","author":"Leriche","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.mtbio.2020.100055_bib87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/1061186X.2015.1108324","article-title":"Smart linkers in polymer\u2013drug conjugates for tumor-targeted delivery","volume":"24","author":"Chang","year":"2016","journal-title":"J.\u00a0Drug Target."},{"key":"10.1016\/j.mtbio.2020.100055_bib88","doi-asserted-by":"crossref","first-page":"101164","DOI":"10.1016\/j.progpolymsci.2019.101164","article-title":"Recent advances in stimuli-responsive polymer systems for remotely controlled drug release","author":"Zhang","year":"2019","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.mtbio.2020.100055_bib89","first-page":"1","article-title":"Riluzole loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress","author":"Nabi","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"7","key":"10.1016\/j.mtbio.2020.100055_bib90","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/adfm.201201663","article-title":"Gold nanoshell nanomicelles for potential magnetic resonance imaging, light-triggered drug release, and photothermal therapy","volume":"23","author":"Ma","year":"2013","journal-title":"Adv. Funct. Mater."},{"issue":"37","key":"10.1016\/j.mtbio.2020.100055_bib91","doi-asserted-by":"crossref","first-page":"1903277","DOI":"10.1002\/adma.201903277","article-title":"ROS-Responsive polymeric siRNA nanomedicine stabilized by triple interactions for the robust glioblastoma combinational RNAi therapy","volume":"31","author":"Zheng","year":"2019","journal-title":"Adv. Mater."},{"issue":"9","key":"10.1016\/j.mtbio.2020.100055_bib92","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1039\/C9MH00482C","article-title":"Switchable nanoparticle for programmed gene-chem delivery with enhanced neuronal recovery and CT imaging for neurodegenerative disease treatment","volume":"6","author":"Liu","year":"2019","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.mtbio.2020.100055_bib93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2013.12.010","article-title":"State-of-the-art materials for ultrasound-triggered drug delivery","volume":"72","author":"Sirsi","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.mtbio.2020.100055_bib94","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative stress in ALS: key role in motor neuron injury and therapeutic target","volume":"48","author":"Barber","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.mtbio.2020.100055_bib95","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/0885328216659032","article-title":"Nanobiomaterials' applications in neurodegenerative diseases","volume":"31","author":"Silva Adaya","year":"2017","journal-title":"J.\u00a0Biomater. Appl."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032616","article-title":"Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease","volume":"7","author":"Mathew","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.mtbio.2020.100055_bib97","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnmol.2014.00080","article-title":"Non-viral gene therapy that targets motor neurons in vivo","volume":"7","author":"Rogers","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.mtbio.2020.100055_bib98","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1021\/acsnano.6b03858","article-title":"Neuron-targeted nanoparticle for siRNA delivery to traumatic brain injuries","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.mtbio.2020.100055_bib99","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.febslet.2009.12.010","article-title":"Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction","volume":"584","author":"Posse de Chaves","year":"2010","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.mtbio.2020.100055_bib100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4103\/1673-5374.182685","article-title":"Antibody-based neuronal and axonal delivery vectors for targeted ligand delivery","volume":"11","author":"Sheikh","year":"2016","journal-title":"Neural Regen. Res."},{"issue":"9","key":"10.1016\/j.mtbio.2020.100055_bib101","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1073\/pnas.1515526113","article-title":"Targeted axonal import (TAxI) peptide delivers functional proteins into spinal cord motor neurons after peripheral administration","volume":"113","author":"Sellers","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mtbio.2020.100055_bib102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neures.2017.09.011","article-title":"The multi-dimensional roles of astrocytes in ALS","volume":"126","author":"Yamanaka","year":"2018","journal-title":"Neurosci. Res."},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib103","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s13346-017-0368-5","article-title":"Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes","volume":"7","author":"Gu","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"issue":"12","key":"10.1016\/j.mtbio.2020.100055_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081043","article-title":"Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro","volume":"8","author":"Gromnicova","year":"2013","journal-title":"PloS One"},{"issue":"52","key":"10.1016\/j.mtbio.2020.100055_bib105","doi-asserted-by":"crossref","first-page":"E12333","DOI":"10.1073\/pnas.1816429115","article-title":"Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection","volume":"115","author":"Surnar","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib106","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12031-016-0833-5","article-title":"Delivery of fluorescent nanoparticles to the brain","volume":"60","author":"Shimoni","year":"2016","journal-title":"J.\u00a0Mol. Neurosci."},{"issue":"46","key":"10.1016\/j.mtbio.2020.100055_bib107","doi-asserted-by":"crossref","first-page":"18837","DOI":"10.1073\/pnas.1111405108","article-title":"Nanoparticles enhance brain delivery of blood\u2013brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging","volume":"108","author":"Koffie","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"20","key":"10.1016\/j.mtbio.2020.100055_bib108","doi-asserted-by":"crossref","first-page":"1603966","DOI":"10.1002\/smll.201603966","article-title":"Multifunctional hybrid nanoparticles for traceable drug delivery and intracellular microenvironment-controlled multistage drug-release in neurons","volume":"13","author":"Shi","year":"2017","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib109","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/adfm.200901108","article-title":"Novel magnetic hydroxyapatite nanoparticles as non-viral vectors for the glial cell line-derived neurotrophic factor gene","volume":"20","author":"Wu","year":"2010","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-9-22","article-title":"Selective targeting of microglia by quantum dots","volume":"9","author":"Minami","year":"2012","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.mtbio.2020.100055_bib111","series-title":"Biomed. Appl. Funct. Nanomater","first-page":"247","article-title":"Graphene-based nanomaterials in bioimaging","author":"Lin","year":"2018"},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib112","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1039\/C2CS35265F","article-title":"Design, functionalization strategies and biomedical applications of targeted biodegradable\/biocompatible polymer-based nanocarriers for drug delivery","volume":"42","author":"Nicolas","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"36","key":"10.1016\/j.mtbio.2020.100055_bib113","doi-asserted-by":"crossref","first-page":"13683","DOI":"10.1039\/C7NR03557H","article-title":"A\u00a0versatile upconversion surface evaluation platform for bio\u2013nano surface selection for the nervous system","volume":"9","author":"Fu","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.mtbio.2020.100055_bib114","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1039\/C9MH00482C","article-title":"Switchable nanoparticle for programmed gene-chem delivery with enhanced neuronal recovery and CT imaging for neurodegenerative disease treatment","volume":"6","author":"Liu","year":"2019","journal-title":"Mater. Horiz."},{"issue":"31","key":"10.1016\/j.mtbio.2020.100055_bib115","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.2174\/0929867321666140916120118","article-title":"The glutamate hypothesis in ALS: pathophysiology and drug development","volume":"21","author":"Blasco","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mtbio.2020.100055_bib116","doi-asserted-by":"crossref","DOI":"10.4103\/2152-7806.169561","article-title":"A\u00a0comprehensive review of amyotrophic lateral sclerosis","volume":"6","author":"Zarei","year":"2015","journal-title":"Surg. Neurol. Int."},{"issue":"6","key":"10.1016\/j.mtbio.2020.100055_bib117","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00018-013-1480-4","article-title":"Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis","volume":"71","author":"Rizzo","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"30","key":"10.1016\/j.mtbio.2020.100055_bib118","doi-asserted-by":"crossref","first-page":"19716","DOI":"10.1021\/acsami.6b01776","article-title":"Enhancement in the neuroprotective power of riluzole against cerebral ischemia using a brain targeted drug delivery vehicle","volume":"8","author":"Verma","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib119","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/nnm.09.67","article-title":"Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution","volume":"5","author":"Bond\u00ec","year":"2010","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib120","first-page":"3","article-title":"Designing novel nanoformulations targeting glutamate transporter excitatory amino acid transporter 2: implications in treating drug addiction","volume":"1","author":"Rao","year":"2015","journal-title":"J.\u00a0Personalized Med."},{"issue":"suppl_3","key":"10.1016\/j.mtbio.2020.100055_bib121","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1093\/cid\/cis559","article-title":"Summary of ceftaroline fosamil clinical trial studies and clinical safety","volume":"55","author":"File","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mtbio.2020.100055_bib122","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.chemphyslip.2016.09.002","article-title":"Synthesis and optimization of ceftriaxone-loaded solid lipid nanocarriers","volume":"200","author":"Kumar","year":"2016","journal-title":"Chem. Phys. Lipids"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib123","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12031-015-0695-2","article-title":"Multifactorial gene therapy enhancing the glutamate uptake system and reducing oxidative stress delays symptom onset and prolongs survival in the SOD1-G93A ALS mouse model","volume":"58","author":"Benkler","year":"2016","journal-title":"J.\u00a0Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.mtbio.2020.100055_bib124","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tibtech.2016.12.009","article-title":"Will nanotechnology bring new hope for gene delivery?","volume":"35","author":"Wong","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/acsnano.6b04261","article-title":"Artificial virus delivers CRISPR-Cas9 system for genome editing of cells in mice","volume":"11","author":"Li","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2020.100055_bib126","first-page":"1885","article-title":"Peptide gh625 enters into neuron and astrocyte cell lines and crosses the blood\u2013brain barrier in rats","volume":"10","author":"Valiante","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2020.100055_bib127","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.omtn.2018.02.007","article-title":"Gene therapy for neuropathic pain through siRNA-IRF5 gene delivery with homing peptides to microglia","volume":"11","author":"Terashima","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"9","key":"10.1016\/j.mtbio.2020.100055_bib128","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.molmed.2019.04.010","article-title":"Astrocytes: emerging therapeutic targets in neurological disorders","volume":"25","author":"Valori","year":"2019","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib129","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7150\/thno.18219","article-title":"Edaravone-encapsulated agonistic micelles rescue ischemic brain tissue by tuning blood-brain barrier permeability","volume":"7","author":"Jin","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2020.100055_bib130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejps.2018.04.026","article-title":"Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: a potent approach to treat amyotrophic lateral sclerosis","volume":"120","author":"Yang","year":"2018","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib131","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40263-016-0317-8","article-title":"Advances in the development of disease-modifying treatments for amyotrophic lateral sclerosis","volume":"30","author":"Moujalled","year":"2016","journal-title":"CNS Drugs"},{"issue":"14","key":"10.1016\/j.mtbio.2020.100055_bib132","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1039\/c3cs35486e","article-title":"Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes","volume":"42","author":"Wei","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib133","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1039\/C8CS00457A","article-title":"Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)","volume":"48","author":"Wu","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"10.1016\/j.mtbio.2020.100055_bib134","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.nano.2016.06.009","article-title":"Cerium oxide nanoparticles with antioxidant properties ameliorate strength and prolong life in mouse model of amyotrophic lateral sclerosis","volume":"12","author":"DeCoteau","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib135","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","article-title":"Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis","volume":"8","author":"Zhao","year":"2013","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib136","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40820-019-0252-6","article-title":"Synthesis and characterization of a silica-based drug delivery system for spinal cord injury therapy","volume":"11","author":"Sun","year":"2019","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.mtbio.2020.100055_bib137","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fneur.2017.00486","article-title":"Immune modulation in the treatment of amyotrophic lateral sclerosis: a review of clinical trials","volume":"8","author":"Khalid","year":"2017","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.mtbio.2020.100055_bib138","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1523\/JNEUROSCI.5253-05.2006","article-title":"Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"26","author":"Kiaei","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.mtbio.2020.100055_bib139","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.colsurfb.2014.11.034","article-title":"Mesenchymal stromal cells loading curcumin-INVITE-micelles: a drug delivery system for neurodegenerative diseases","volume":"125","author":"Tripodo","year":"2015","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.mtbio.2020.100055_bib140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jtemb.2014.12.012","article-title":"Neurodegenerative diseases and therapeutic strategies using iron chelators","volume":"31","author":"Ward","year":"2015","journal-title":"J.\u00a0Trace Elem. Med. Biol."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib141","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/187152712799960709","article-title":"Nanoparticle delivery of transition-metal chelators to the brain: oxidative stress will never see it coming!","volume":"11","author":"Bonda","year":"2012","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib142","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neulet.2006.07.020","article-title":"Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance","volume":"406","author":"Liu","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib143","doi-asserted-by":"crossref","first-page":"1703458","DOI":"10.1002\/adma.201703458","article-title":"Black phosphorus nanosheets as a neuroprotective nanomedicine for neurodegenerative disorder therapy","volume":"30","author":"Chen","year":"2018","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.mtbio.2020.100055_bib144","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3109\/10715762.2012.714466","article-title":"Are oxidative stress and mitochondrial dysfunction the key players in the neurodegenerative diseases?","volume":"46","author":"Di Carlo","year":"2012","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.mtbio.2020.100055_bib145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2015.12.024","article-title":"Nanotechnology inspired tools for mitochondrial dysfunction related diseases","volume":"99","author":"Wen","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"30","key":"10.1016\/j.mtbio.2020.100055_bib146","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1002\/anie.201805052","article-title":"Ceria nanoparticle systems for selective scavenging of mitochondrial, intracellular, and extracellular reactive oxygen species in Parkinson's disease","volume":"57","author":"Kwon","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib147","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","article-title":"Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer's disease","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib148","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/brain\/awq314","article-title":"SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse","volume":"134","author":"Fischer","year":"2010","journal-title":"Brain"},{"issue":"2\u20133","key":"10.1016\/j.mtbio.2020.100055_bib149","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s12010-008-8232-1","article-title":"Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress","volume":"151","author":"Reddy","year":"2008","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5607\/en.2015.24.1.1","article-title":"Prion-like mechanism in amyotrophic lateral sclerosis: are protein aggregates the key?","volume":"24","author":"Lee","year":"2015","journal-title":"Exp. Neurobiol."},{"issue":"7628","key":"10.1016\/j.mtbio.2020.100055_bib151","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib152","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","article-title":"TDP-43 proteinopathy and ALS: insights into disease mechanisms and therapeutic targets","volume":"12","author":"Scotter","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mtbio.2020.100055_bib153","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/jnc.13625","article-title":"Physiological functions and pathobiology of TDP-43 and FUS\/TLS proteins","volume":"138","author":"Ratti","year":"2016","journal-title":"J.\u00a0Neurochem."},{"issue":"7650","key":"10.1016\/j.mtbio.2020.100055_bib154","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","article-title":"Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice","volume":"544","author":"Becker","year":"2017","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.mtbio.2020.100055_bib155","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.molmed.2015.06.001","article-title":"Gene therapy for neurodegenerative diseases","volume":"21","author":"O'Connor","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib156","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/A:1016123413038","article-title":"Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis","volume":"7","author":"Manabe","year":"2002","journal-title":"Apoptosis"},{"key":"10.1016\/j.mtbio.2020.100055_bib157","series-title":"Gene Therapy for Neurological Disorders","first-page":"325","article-title":"Ex vivo gene therapy using human mesenchymal stem cells to deliver growth factors in the skeletal muscle of a familial ALS rat model","author":"Suzuki","year":"2016"},{"issue":"2","key":"10.1016\/j.mtbio.2020.100055_bib158","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s13311-015-0344-z","article-title":"RNA-targeted therapeutics for ALS","volume":"12","author":"Reddy","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mtbio.2020.100055_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.06.023","article-title":"Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems","volume":"236","author":"Rezaee","year":"2016","journal-title":"J.\u00a0Contr. Release"},{"issue":"7","key":"10.1016\/j.mtbio.2020.100055_bib160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/14712598.2015.1044894","article-title":"Current developments in gene therapy for amyotrophic lateral sclerosis","volume":"15","author":"Scarrott","year":"2015","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.mtbio.2020.100055_bib161","doi-asserted-by":"crossref","first-page":"16023","DOI":"10.1038\/mtm.2016.23","article-title":"Production and clinical development of nanoparticles for gene delivery","volume":"3","author":"Chen","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.mtbio.2020.100055_bib162","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fnins.2017.00476","article-title":"Improving the delivery of SOD1 antisense oligonucleotides to motor neurons using calcium phosphate-lipid nanoparticles","volume":"11","author":"Chen","year":"2017","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib163","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.apsb.2018.12.010","article-title":"Small interfering RNA delivery to the neurons near the amyloid plaques for improved treatment of Alzheimer\u05f3 s disease","volume":"9","author":"Guo","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib164","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000447559","article-title":"Brain-derived neurotrophic factor facilitates functional recovery from ALS-cerebral spinal fluid-induced neurodegenerative changes in the NSC-34 motor neuron cell line","volume":"17","author":"Shruthi","year":"2017","journal-title":"Neurodegener. Dis."},{"issue":"25","key":"10.1016\/j.mtbio.2020.100055_bib165","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1002\/adma.201200634","article-title":"Nanoporous peptide particles for encapsulating and releasing neurotrophic factors in an animal model of neurodegeneration","volume":"24","author":"Tan","year":"2012","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib166","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/ijms18030663","article-title":"Brain-derived neurotrophic factor loaded PS80 PBCA nanocarrier for in vitro neural differentiation of mouse induced pluripotent stem cells","volume":"18","author":"Chung","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2020.100055_bib167","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.2147\/IJN.S30919","article-title":"Neurological disorders and therapeutics targeted to surmount the blood\u2013brain barrier","volume":"7","author":"Kanwar","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.mtbio.2020.100055_bib168","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1080\/10717544.2016.1199609","article-title":"Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury","volume":"23","author":"Khalin","year":"2016","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib169","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrn3380","article-title":"Axonal transport deficits and neurodegenerative diseases","volume":"14","author":"Millecamps","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.mtbio.2020.100055_bib170","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1073\/pnas.1200658109","article-title":"Axonal transport deficits and degeneration can evolve independently in mouse models of amyotrophic lateral sclerosis","volume":"109","author":"Marinkovi\u0107","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.mtbio.2020.100055_bib171","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000107704","article-title":"Axonal degeneration in motor neuron disease","volume":"4","author":"Fischer","year":"2007","journal-title":"Neurodegener. Dis."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib172","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","article-title":"HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2020.100055_bib173","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.2147\/IJN.S136142","article-title":"Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer","volume":"12","author":"Yuan","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.mtbio.2020.100055_bib174","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7150\/thno.13725","article-title":"Histone deacetylase inhibitors delivery using nanoparticles with intrinsic passive tumor targeting properties for tumor therapy","volume":"6","author":"El Bahhaj","year":"2016","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.mtbio.2020.100055_bib175","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/13543784.2019.1627324","article-title":"Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials","volume":"28","author":"Goutman","year":"2019","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.mtbio.2020.100055_bib176","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2741\/4016","article-title":"Nanotechnology in stem cells research: advances and applications","volume":"17","author":"Deb","year":"2012","journal-title":"Front. Biosci."},{"issue":"19","key":"10.1016\/j.mtbio.2020.100055_bib177","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.biomaterials.2012.03.047","article-title":"Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles","volume":"33","author":"Wang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2020.100055_bib178","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.addr.2019.02.007","article-title":"Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders","volume":"148","author":"Vissers","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2020.100055_bib179","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.msec.2017.03.303","article-title":"Nerve growth factor-loaded heparinized cationic solid lipid nanoparticles for regulating membrane charge of induced pluripotent stem cells during differentiation","volume":"77","author":"Kuo","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib180","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41467-017-00952-3","article-title":"Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain","volume":"8","author":"Anraku","year":"2017","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.mtbio.2020.100055_bib181","doi-asserted-by":"crossref","first-page":"1605563","DOI":"10.1002\/adma.201605563","article-title":"Rabies virus-inspired silica-coated gold nanorods as a photothermal therapeutic platform for treating brain tumors","volume":"29","author":"Lee","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2020.100055_bib182","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J.\u00a0Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib183","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.addr.2012.08.008","article-title":"Exosomes for targeted siRNA\u00a0delivery across biological barriers","volume":"65","author":"Andaloussi","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib184","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mtbio.2020.100055_bib185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ebiom.2018.01.002","article-title":"Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-\u03b3","volume":"28","author":"Kim","year":"2018","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.mtbio.2020.100055_bib186","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1021\/acsnano.9b01004","article-title":"Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders","volume":"13","author":"Riazifar","year":"2019","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib187","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J.\u00a0Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.mtbio.2020.100055_bib188","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2015.01.001","article-title":"Cancer nanomedicine: from targeted delivery to combination therapy","volume":"21","author":"Xu","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib189","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng. Transl. Med."},{"issue":"1","key":"10.1016\/j.mtbio.2020.100055_bib190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jat.3476","article-title":"Potential applications and human biosafety of nanomaterials used in nanomedicine","volume":"38","author":"Su","year":"2018","journal-title":"J.\u00a0Appl. Toxicol."},{"issue":"3","key":"10.1016\/j.mtbio.2020.100055_bib191","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2217\/nnm.12.3","article-title":"Challenges posed by the scale-up of nanomedicines","volume":"7","author":"Muthu","year":"2012","journal-title":"Nanomedicine"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006420300156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006420300156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:14:17Z","timestamp":1762906457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006420300156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":191,"alternative-id":["S2590006420300156"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2020.100055","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2020.100055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100055"}}